October 26, 2025

Get In Touch

FSSAI Bans Misleading ORS Drinks That Could Aggravate Dehydration Risks

The Food Safety and Standards Authority of India (FSSAI) has banned the use of the term "Oral Rehydration Salts" (ORS) or its abbreviation on any food or beverage product unless it strictly adheres to World Health Organization (WHO) standards. This directive, issued on October 14, also revoked previous permissions that allowed brands to use "ORS" with disclaimers, closing loopholes that misled consumers by equating sugary drinks with medicinal rehydration solutions. The ban is credited to Hyderabad paediatrician Dr Sivaranjani Santosh, who campaigned for nearly a decade against the misuse of the ORS label, warning of risks to children and diabetics, reports Telegraph India. The WHO-approved ORS formula balances salts and glucose to treat dehydration effectively, unlike many sugary market drinks that can worsen dehydration and cause salt toxicity. FSSAI now mandates strict compliance, warning food business operators that misleading labeling violates the Food Safety and Standards Act, 2006, with penalties up to Rs 10 lakh.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!